Using Predictive Classifiers in the Design of Phase III Clinical Trials Richard Simon, D.Sc. Chief, Biometric Research Branch National Cancer Institute.
Introduction to Design of Genomic Clinical Trials
Using Predictive Classifiers in the Design of Phase III Clinical Trials